Imegen

Paterna, Spain Founded: 2009 • Age: 17 yrs Acquired By Alantra
Genetic tests for detecting diseases across medical fields are provided.

About Imegen

Imegen is a Healthcare company based in Paterna (Spain) founded in 2009 by Manuel Perez Alonso, and was acquired by Alantra in December 2019. Genetic tests for detecting diseases across medical fields are provided. Its chief executive, as recorded, is Angela Perez. Its focus areas include Life Sciences, Rare Diseases, In Vitro Diagnostic Tests and Oncology.

Company details

Imegen was established in 2009 in Paterna, Spain, as a provider in the genomics sector. Diagnostic tests for conditions in hematology, oncology, cardiology, neurology, pediatrics, endocrinology, and immunology are offered. Gene analysis services and personalized genetic consultations with genomic medicine specialists are also provided. Operations center on healthcare diagnostics within the European market.

  • Headquarters Paterna, Spain
  • Founders Manuel Perez Alonso
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website imegen.es
  • Social LinkedIn X Facebook
  • Acquired by Alantra (Dec 2019)
Key Metrics

Funding Insights of Imegen

  • Total Rounds 2
  • First Round $139,686

    (May 2016)

  • Investors Count 2

All 2 funding rounds of Imegen with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2017Series A––
May 2016$139,686Grant––
Valuation history

3 investors in total: 3 institutional.

Investors in Imegen

Imegen has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Alantra, European Union and Qualitas Equity Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm & funds of funds investing in SMEs
qualitasequity.comMadrid, Spain
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Global mid-market investment banking services are provided across sectors.
2001alantra.comLondon, United Kingdom
Premium access

Investor details for Imegen

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Imegen

2 people are tracked at Imegen (2 in leadership).

NameRoleGroup
Manuel Perez Alonso
FounderLeadership
Angela Perez
CEOLeadership
Premium access

Complete people profiles for Imegen

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Imegen

4 dated milestones of Imegen across 10 years, from founding to its latest funding, stage changes and deals.

  1. Founded Imegen is founded.
  2. Funding First funding round of $140K.
  3. Funding Latest funding round, Series A,.
  4. Exit Acquired by Alantra.

Web traffic of Imegen

Websites that share an audience with Imegen (imegen.es).

Similar websites

Websites whose visitors overlap most with Imegen. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
intraumatologico.cl
intraumatologico.cl
100%
#3,622,993–
labtestsonline.es
labtestsonline.es
99%
#411,218–
revistas.isciii.es
revistas.isciii.es
99%
–
biotec.com.uy
biotec.com.uy
99%
#4,344,142–
institutoroche.es
institutoroche.es
99%
#955,228–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 7 similar websites and full traffic analytics for Imegen

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 7 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Imegen

Premium access

Complete news archive for Imegen

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Imegen

Imegen was founded in 2009 and raised its 1st funding round 7 years after it was founded.

Imegen is headquartered in Paterna, Spain. It is registered at Paterna, Valencian Community, Spain.

Angela Perez is the CEO of Imegen, as recorded in our data.

Imegen was established in 2009 in Paterna, Spain, as a provider in the genomics sector. Diagnostic tests for conditions in hematology, oncology, cardiology, neurology, pediatrics, endocrinology, and immunology are offered. Gene analysis services and personalized genetic consultations with genomic medicine specialists are also provided. Operations center on healthcare diagnostics within the European market.

Imegen has 3 investors. Key investors include Alantra, European Union, and Qualitas Equity Partners.

Yes. Imegen was acquired by Alantra in December 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available